VTRS Viatris Inc.
$17.83
Viatris Inc. (VTRS) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $0.65 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.8% since its last earnings release on August 6, 2026.
Viatris Beat Expectations, Raises Guidance, but Remains In-line with Estimates
Thursday, August 6, 2026 · 6:59 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:00 AM ET
Earnings Whisper
-
vs $0.65
Rev est $3.8B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$16.54
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Viatris Inc.
Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life.
Sector
Healthcare
Industry
Drugs - Generic
Held By 14 ETFs, by dollar flow
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- PPH VanEck Pharmaceutical ETF
- PPH VanEck Pharmaceutical ETF
- XPH SPDR S&P Pharmaceuticals ETF
- XPH SPDR S&P Pharmaceuticals ETF
- IHE iShares U.S. Pharmaceuticals ETF
- IHE iShares U.S. Pharmaceuticals ETF
Charts powered in part by Lightweight Charts™ by TradingView.